U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H2O4
Molecular Weight 90.0349
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Oxalic Acid

SMILES

OC(=O)C(O)=O

InChI

InChIKey=MUBZPKHOEPUJKR-UHFFFAOYSA-N
InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)

HIDE SMILES / InChI

Molecular Formula C2H2O4
Molecular Weight 90.0349
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Two-dimensional coordination polymers of copper(II) with oxalate: lattice water control of structure.
2001-06-04
Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
2001-06
Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
2001-06
Cystine calculi in children: the results of a metabolic evaluation and response to medical therapy.
2001-06
New methods for the isolation of skeletal muscle sarcolemma and sarcoplasmic reticulum allowing a comparison between the mammalian and amphibian beta(2)-adrenergic receptors and calcium pumps.
2001-06
Effects of hydrochlorothiazide and diet in dogs with calcium oxalate urolithiasis.
2001-05-15
Simple, sensitive and accurate method for the quantification of prothrombin mRNA by using competitive PCR.
2001-05-15
A GTP-dependent vertebrate-type phosphoenolpyruvate carboxykinase from Mycobacterium smegmatis.
2001-05-11
Histological diagnosis of mucopolysaccharidosis IIIA in a wire-haired dachshund.
2001-05-05
Effects of sialic acid residues of transferrin on the binding with aluminum and iron studied by HPLC/high-resolution ICP-MS.
2001-05-03
Effect of several organic acids on phosphate adsorption by variable charge soils of central China.
2001-05
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.
2001-05
A critical appraisal of the hypothesis that urine is a saturated equilibrium with respect to stone-forming calcium salts.
2001-05
Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
2001-05
[Study of renal function in infants diagnosed with renal pyelectasis in the first year of life].
2001-05
Oxidation of lignin in eucalyptus kraft pulp by manganese peroxidase from Bjerkandera sp. strain BOS55.
2001-05
Mechanisms of wood degradation by brown-rot fungi: chelator-mediated cellulose degradation and binding of iron by cellulose.
2001-04-27
Tooth surface pH during drinking of black tea.
2001-04-14
ESR study of the non-enzymic scission of xyloglucan by an ascorbate-H2O2-copper system: the involvement of the hydroxyl radical and the degradation of ascorbate.
2001-04
Rethinking the role of urinary magnesium in calcium urolithiasis.
2001-04
Urine volume and its effects on renal stone risk in astronauts.
2001-04
Does exhaustive search for microcalcifications improve diagnostic yield in stereotactic core needle breast biopsies?
2001-04
Study of two plants used in traditional medicine in Zimbabwe for skin problems and rheumatism: Dioscorea sylvatica and Urginea altissima.
2001-04
Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease.
2001-03-29
Calcium oxalate microdeposition in failing kidney grafts.
2001-03-27
Simultaneous measurement of dopamine and ascorbate at their physiological levels using voltammetric microprobe based on overoxidized poly(1,2-phenylenediamine)-coated carbon fiber.
2001-03-15
The simplest supramolecular complexes containing pairs of Mo(2)(formamidinate)(3) units linked with various dicarboxylates: preparative methods, structures, and electrochemistry.
2001-03-12
Thermally induced changes in metal solubility of contaminated soils is linked to mineral recrystallization and organic matter transformations.
2001-03-01
Hippuric acid as a modifier of calcium oxalate crystallisation.
2001-03
Chitooligosaccharide-induced activation of o-phenylenediamine oxidation by wheat seedlings in the presence of oxalic acid.
2001-03
An evaluation of the physicochemical risk for renal stone disease during pregnancy.
2001-03
Synthesis and muscarinic activity of 1,2,3,4-tetrahydropyrimidine derivatives.
2001-03
Mediaeval cantorals in the Valladolid Biblioteca: FT-Raman spectroscopic study.
2001-03
Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
2001-03
Characterization of oxalate oxidase and cell death in Al-sensitive and tolerant wheat roots.
2001-03
Approaching zero discharge in uranium reprocessing: photochemical reduction of uranyl.
2001-02-01
Morphology and anatomy of developing fruits and seeds of Vismia guianensis (Aubl.) Choisy (Clusiaceae).
2001-02
Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model.
2001-02
The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index.
2001-02
Renal tubular injury induced by hyperoxaluria: evaluation of apoptotic changes.
2001-02
Modelling of auxin-binding protein 1 suggests that its C-terminus and auxin could compete for a binding site that incorporates a metal ion and tryptophan residue 44.
2001-02
[Photooxidation of acridine orange in homogeneous system containing Fe3+ and H2O2 under visible irradiation].
2001-01
Arsenic characterisation in industrial soils by chemical extractions.
2001-01
Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.
2001-01
Improvement of a standard MIRA method for urinary oxalate by elimination of reagent carry-over.
2001-01
Automatic segmentation of medical images for renal calculi and analysis.
2001
Inhibition of potato polyphenol oxidase by anions and activity in various carboxylate buffers (pH 4.8) at constant ionic strength.
2001
Upregulation of the SERCA-type Ca2+ pump activity in response to endoplasmic reticulum stress in PC12 cells.
2001
A common carbanion intermediate in the recombination and proton-catalysed disproportionation of the carboxyl radical anion, CO2*-, in aqueous solution.
2001
The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:26:54 GMT 2025
Edited
by admin
on Mon Mar 31 18:26:54 GMT 2025
Record UNII
9E7R5L6H31
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Oxalic Acid
HSDB   INCI   MI   VANDF   WHO-DD  
INCI  
Official Name English
OXALIPLATIN RELATED COMPOUND A
USP  
Preferred Name English
Oxalic acid [WHO-DD]
Common Name English
OXALIC ACID [HSDB]
Common Name English
ETHANEDIOIC ACID
Systematic Name English
NSC-62774
Code English
OXALIC ACID [VANDF]
Common Name English
OXALIPLATIN RELATED COMPOUND A [USP-RS]
Common Name English
OXALIC ACID [MI]
Common Name English
OXALIPLATIN IMPURITY A [EP IMPURITY]
Common Name English
OXALIPLATIN RELATED COMPOUND A [USP IMPURITY]
Common Name English
Classification Tree Code System Code
LOINC 13483-3
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 20927-0
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
EPA PESTICIDE CODE 9601
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 34350-9
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 2699-7
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 2700-3
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 47715-8
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 27222-9
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 14861-9
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 57375-8
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 20928-8
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 57373-3
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 15085-4
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 26796-3
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 15086-2
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 57374-1
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 34349-1
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 49937-6
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 55961-7
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
WHO-VATC QP53AG03
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 14862-7
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 13788-5
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
LOINC 2701-1
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
Code System Code Type Description
CHEBI
30623
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
EVMPD
SUB32959
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
DRUG BANK
DB03902
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
CHEBI
16995
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
MERCK INDEX
m8280
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY Merck Index
FDA UNII
9E7R5L6H31
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
RXCUI
1427058
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY RxNorm
PUBCHEM
971
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
NCI_THESAURUS
C84036
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-634-3
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
MESH
D019815
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
NSC
62774
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
RS_ITEM_NUM
1481215
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
WIKIPEDIA
OXALIC ACID
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
RXCUI
1441660
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
CONCEPT Industrial Aid
EPA CompTox
DTXSID0025816
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
CAS
144-62-7
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
DAILYMED
9E7R5L6H31
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
SMS_ID
100000125910
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
HSDB
1100
Created by admin on Mon Mar 31 18:26:54 GMT 2025 , Edited by admin on Mon Mar 31 18:26:54 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
ASSAY (COLORIMETRIC)
USP
PARENT -> IMPURITY
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY